psalexa
logo

Smoking Cessation Market

Global Smoking Cessation Market Size, Share, Development, Growth and Demand Forecast to 2023

Delivery : 24-72 Working Hours
Report Code: LS10532
Available Format:
Category : Healthcare

Chapter 1. Research Background

1.1. Research Objectives

1.2. Market Definition

1.3. Research Scope

1.3.1. Market Segmentation by Therapy

1.3.2. Market Segmentation by Product

1.3.3. Market Segmentation by Geography

1.3.4. Analysis Period

1.4. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research

2.2. Primary Research

2.2.1. Breakdown of Primary Research Respondents

2.2.1.1. By region

2.2.1.2. By industry participants

2.2.1.3. By company type

2.3. Market Size Estimation

2.4. Market Breakdown and Data Triangulation

2.5. Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1. Market Segmentation

4.1.1. Overview by Therapy

4.1.1.1. Nicotine replacement therapy(NRT)

4.1.1.1.1. NicoDerm CQ

4.1.1.1.2. Nicotrol

4.1.1.1.3. Habitrol(Nicotinell)

4.1.1.1.4. Nicorette

4.1.1.1.5. Niquitin

4.1.1.2. Non-NRT therapy

4.1.1.2.1. Prescription drug

4.1.1.2.1.1. Chantix

4.1.1.2.1.2. Zyban/Wellbutrin

4.1.1.2.2. E-cigarette

4.1.2. Overview by Product Type

4.1.2.1. Chewing gum

4.1.2.2. Patch

4.1.2.3. Lozenge

4.1.2.4. Sublingual tablets

4.1.2.5. Spray

4.1.2.6. Inhaler

4.2. Value Chain Analysis

4.3. Market Dynamics

4.3.1. Trends

4.3.2. Drivers

4.3.2.1. Impact analysis of drivers on market forecast

4.3.3. Restraints

4.3.3.1. Impact analysis of restraints on market forecast

4.3.4. Opportunities

4.4. Porter’s Five Forces Analysis

Chapter 5. Market Size and Forecast by Therapy

5.1. Nicotine Replacement Therapy(NRT)

5.1.1. NicoDerm CQ

5.1.2. Nicotrol

5.1.3. Habitrol(Nicotinell)

5.1.4. Nicorette

5.1.5. Niquitin

5.2. Non-NRT Therapy

5.2.1. Prescription drug

5.2.1.1. Chantix

5.2.1.2. Zyban/Wellbutrin

5.2.2. E-cigarette/E-liquids

Chapter 6. Market Size and Forecast by Product Type

6.1.1. Chewing gum

6.1.2. Patch

6.1.3. Lozenges

6.1.4. Sublingual Tablets

6.1.5. Spray

6.1.6. Inhaler

Chapter 7. Market Size and Forecast by Geography

7.1. North America Smoking Cessation Market

7.1.1. By Therapy

7.1.2. By Product Type

7.1.3. By Country-The U.S, Canada and Others

7.2. Europe Smoking Cessation Market

7.2.1. By Therapy

7.2.2. By Product Type

7.2.3. By Country –Germany, France, U.K and others

7.3.  Latin America Smoking Cessation Market

7.3.1. By Therapy

7.3.2. By Product Type

7.3.3. By Country –Brazil and Mexico

7.4.  Asia-Pacific Smoking Cessation Market

7.4.1. By Therapy

7.4.2. By Product Type

7.4.3. By Country -China, Japan, India and others

7.5. Middle East and Africa Smoking Cessation Market

7.5.1. By Therapy

7.5.2. By Product Type

7.5.3. By Country

Chapter 8. Competitive Landscape

8.1. Market Share Analysis of Major Players

8.2. Competitive Analysis of Key Players

8.3. Global Strategic Developments

Chapter 9. Company Profiles

9.1. Pfizer

9.1.1. Business Overview

9.1.2. Product and Service Offerings

9.1.3. Key Financial Summary

9.1.4. Strategic Growth Plan

9.2. GlaxoSmithKline (GSK)

9.2.1. Business Overview

9.2.2. Product and Service Offerings

9.2.3. Key Financial Summary

9.2.4. Strategic Growth Plan

9.3. Novartis

9.3.1. Business Overview

9.3.2. Product and Service Offerings

9.3.3. Key Financial Summary

9.3.4. Strategic Growth Plan

9.4. Johnson & Johnson (J&J)

9.4.1. Business Overview

9.4.2. Product and Service Offerings

9.4.3. Key Financial Summary

9.4.4. Strategic Growth Plan

9.5. Perrigo

9.5.1. Business Overview

9.5.2. Product and Service Offerings

9.5.3. Key Financial Summary

9.5.4. Strategic Growth Plan

9.6.  Reynolds American Inc.

9.6.1. Business Overview

9.6.2. Product and Service Offerings

9.6.3. Key Financial Summary

9.6.4. Strategic Growth Plan

9.7. VMR Products LLC

9.7.1. Business Overview

9.7.2. Product and Service Offerings

9.7.3. Key Financial Summary

9.7.4. Strategic Growth Plan

9.8.   British American Tobacco PLC

9.8.1. Business Overview

9.8.2. Product and Service Offerings

9.8.3. Key Financial Summary

9.8.4. Strategic Growth Plan

9.9. Nicotek LLC

9.9.1. Business Overview

9.9.2. Product and Service Offerings

9.9.3. Key Financial Summary

9.9.4. Strategic Growth Plan

9.10.  Njoy Inc.

9.10.1. Business Overview

9.10.2. Product and Service Offerings

9.10.3. Key Financial Summary

9.10.4. Strategic Growth Plan

*Note: Key financial summary and strategic growth plan will be provided on best effort basis and is subject to availability during primary and secondary research.

Chapter 10. Appendix

10.1. Abbreviations

Place An Order

Single User License
question-mark

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 5100
Group License
question-mark

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 6100
Enterprise License
question-mark

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 9100

Pre-Purchase Enquiry